The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -36.52%.However, over the last six months, we can see a stronger performance of -73.04%. Over the last 30 days, the price of KZIA has leaped by -29.71%. And in the last five days, it has surged by 24.44%.
Kazia Therapeutics Limited ADR experienced a rather shaky stock market performance. The highest value in the past year was recorded at $1.68 on 04/18/23 and the lowest value was $0.19 on 03/06/24.
52-week price history of KZIA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Kazia Therapeutics Limited ADR’s current trading price is -83.39% away from its 52-week high, while its distance from the 52-week low is 49.52%. The stock’s price range during this period has varied between$0.19 and $1.68. The Kazia Therapeutics Limited ADR’s shares, which operate in the Healthcare, saw a trading volume of around 0.66 million for the day, a figure considerably lower than their average daily volume of 0.74 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Kazia Therapeutics Limited ADR (KZIA) has experienced a quarterly decline of -30.25% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.59M.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4066, with a change in price of -0.3110. Similarly, Kazia Therapeutics Limited ADR recorded 503,755 in trading volume during the last 100 days, posting a change of -52.71%.
KZIA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for KZIA stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.00.
KZIA Stock Stochastic Average
Kazia Therapeutics Limited ADR’s raw stochastic average for the past 50 days is presently 35.11%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 64.44%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 35.94% and 23.44%, respectively.
